Cabaletta Bio, Inc. (CABA)
3.73
-0.42
(-10.12%)
USD |
NASDAQ |
May 06, 16:00
3.77
+0.04
(+1.07%)
After-Hours: 07:02
Cabaletta Bio Market Cap : 415.23M for May 6, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Anavex Life Sciences Corp. | 309.52M |
| ACADIA Pharmaceuticals, Inc. | 3.662B |
| Alnylam Pharmaceuticals, Inc. | 40.45B |
| Savara, Inc. | 1.079B |
| BioMarin Pharmaceutical, Inc. | 10.55B |
Market Cap Related Metrics
| Price to Book Value | 3.706 |
| Price | 3.73 |
| Earnings Yield | -61.49% |